Standout Papers
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus (2013)
- Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs (2017)
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial (2014)
- Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors (2017)
- Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death (2015)
- Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (2025)
Immediate Impact
4 from Science/Nature 117 standout
Citing Papers
Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction
2023 Standout
Gliflozins in the Management of Cardiovascular Disease
2022 Standout
Works of Matthew A. Cavender being referenced
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
2020
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death
2015 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Matthew A. Cavender | 2280 | 2025 | 4558 | 83 | 6.5k | |
| Stuart Kupfer | 2259 | 1292 | 3867 | 78 | 5.5k | |
| Jacob A. Udell | 3000 | 2305 | 5196 | 158 | 8.4k | |
| Gérald Luc | 2947 | 3067 | 2544 | 87 | 8.9k | |
| Jaime A. Davidson | 1093 | 2612 | 6384 | 97 | 7.9k | |
| Jennifer B. Green | 1445 | 1264 | 3500 | 89 | 4.7k | |
| Samuel S. Engel | 736 | 1178 | 3608 | 126 | 4.9k | |
| Gilbert H. Daniels | 1384 | 3098 | 9381 | 98 | 11.9k | |
| Paola Fioretto | 1876 | 1981 | 3942 | 191 | 9.8k | |
| KyungAh Im | 1493 | 1440 | 3380 | 47 | 4.5k | |
| Michael Szarek | 2204 | 3713 | 3156 | 120 | 7.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...